Sana Biotechnology, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $-13.2M | $31.4M |
| Dec 2019 | — | $-142.5M | $81.8M |
| Mar 2020 | — | $-174.7M | $91.4M |
| Jun 2020 | — | $-260.9M | $457.2M |
| Sep 2020 | — | $-311.2M | $151.4M |
| Dec 2020 | — | $-421.2M | $124.8M |
| Mar 2021 | — | $882.0M | $750.7M |
| Jun 2021 | — | $905.9M | $675.1M |
| Sep 2021 | — | $830.1M | $433.7M |
| Dec 2021 | — | $728.5M | $253.0M |
| Mar 2022 | — | $701.7M | $188.5M |
| Jun 2022 | — | $639.5M | $194.7M |
| Sep 2022 | — | $566.0M | $163.3M |
| Dec 2022 | — | $499.3M | $176.8M |
| Mar 2023 | — | $428.3M | $160.5M |
| Jun 2023 | — | $355.0M | $173.8M |
| Sep 2023 | — | $365.9M | $168.4M |
| Dec 2023 | — | $287.5M | $133.5M |
| Mar 2024 | — | $375.1M | $177.1M |
| Jun 2024 | — | $339.6M | $135.0M |
| Sep 2024 | — | $292.5M | $127.0M |
| Dec 2024 | — | $250.5M | $127.6M |
| Mar 2025 | — | $209.1M | $96.1M |
| Jun 2025 | — | $122.6M | $71.3M |
| Sep 2025 | — | $195.3M | $103.4M |
| Dec 2025 | — | $160.9M | $71.9M |
| Mar 2026 | — | $119.2M | $83.8M |
| Jun 2026 | — | $154.6M | $57.1M |